Literature DB >> 7820418

Partial nephrectomy for incidental renal cell carcinoma.

H W Herr1.   

Abstract

OBJECTIVE: To evaluate the role of nephron-sparing surgery in patients with incidental renal cell carcinoma and a normal contralateral kidney. PATIENTS AND METHODS: A total of 230 patients underwent curative surgery for unilateral renal cancer between 1979 and 1991. Of these, 41 had a partial nephrectomy. The numbers of patients who underwent partial or radical nephrectomy over the course of the study are compared.
RESULTS: The number of partial compared to total nephrectomies increased from 8% in 1979-84, to 20% in 1984-88 and 30% in 1989-91. This reflected increased detection of incidental renal tumours by radiological imaging. The local recurrence rate in those patients who underwent partial nephrectomy was 2% and survival was 95%, with an average follow-up of 3 years (range, 2-13).
CONCLUSION: Nephron-sparing excision of small, incidental renal tumours achieved comparable early results to radical nephrectomy.

Entities:  

Mesh:

Year:  1994        PMID: 7820418     DOI: 10.1111/j.1464-410x.1994.tb00417.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  Water-jet dissection in renal surgery: experimental study of a new device in the pig.

Authors:  J Hubert; E Mourey; J M Suty; A Coissard; J Floquet; P Mangin
Journal:  Urol Res       Date:  1996

2.  Changes in clinicopathological characteristics of renal cell carcinoma in the past 25 years: a single-center experience.

Authors:  Jin Bong Choi; Byung Il Yoon; Su Jin Kim; Hyuk Jin Cho; Sung-Hoo Hong; Yeong Jin Choi; Sae Woong Kim; Tae-Kon Hwang; Ji Youl Lee
Journal:  Korean J Urol       Date:  2011-02-21

3.  Ischemia Techniques in Nephron-sparing Surgery: A Systematic Review and Meta-Analysis of Surgical, Oncological, and Functional Outcomes.

Authors:  Francesco Greco; Riccardo Autorino; Vincenzo Altieri; Steven Campbell; Vincenzo Ficarra; Inderbir Gill; Alexander Kutikov; Alex Mottrie; Vincenzo Mirone; Hendrik van Poppel
Journal:  Eur Urol       Date:  2018-10-13       Impact factor: 24.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.